Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
Orion
7112 investors follow this company
BUY 38.93 LOWEST 36.93 VOLUME 491 765
SELL 38.99 HIGHEST 39.20 VALUE 18,944 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Analyytikko

Petri Kajaani
+358 50 527 8680

Upcoming events

28
Apr
Osavuosikatsaukset

Latest insider trading

Type: stock_exchange_release
30.3.
2020

ORION CORPORATION PRESS RELEASE 30 MARCH 2020 at 18.15 EEST             

Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer         

Type: stock_exchange_release
19.3.
2020

ORION CORPORATION STOCK EXCHANGE RELEASE 19 MARCH 2020 at 12.20 EET             
         

Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date

Due to the development of the coronavirus situation and the announcements by the Finnish Government, Orion’s Board of Directors has decided to cancel the Annual General Meeting convened for Wednesday 25 March 2020.  

Type: stock_exchange_release
5.3.
2020

ORION CORPORATION       STOCK EXCHANGE RELEASE       5 MARCH 2020 at 10.25 a.m. EET             
         

Orion Corporation: Change in Orion Group Executive Management Board as of 1 April 2020

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Satu Ahomäki

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Timo Lappalainen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Virve Laitinen

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Liisa Hurme

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Christer Nordstedt

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 3rd March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Markku Huhta-Koivisto

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Type: stock_exchange_release
3.3.
2020

ORION CORPORATION      MANAGERS’ TRANSACTIONS 03 March 2020 at 11.30 EET

Orion Corporation: Managers’ transactions – Olli Huotari

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion

Orion lyhyesti

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.